No annual revenue total was found in CTT PHARMACEUTICAL HOLDINGS, INC.'s SEC filings.
CTT Pharmaceutical Holdings, Inc. (CTTH) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
$-672,162
-3454.3% vs prior year
Operating cash flow
$-72,250
-34469.4% vs prior year
Free cash flow
—
EPS
$0.01
+109.1% vs prior year
Dividend per share
None
Shares outstanding
21.35M
-89.1% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTTH (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Tampa, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1035422
- Former names
- Mindesta Inc. (until Jul 21, 2015); INDUSTRIAL MINERALS INC (until Jul 18, 2011); PNW CAPITAL INC (until May 21, 2002); WINCHESTER MINING CORP (until May 26, 2000)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2014 Dec 31, 2014 |
FY 2013 Dec 31, 2013 |
FY 2012 Dec 31, 2012 |
FY 2011 Dec 31, 2011 |
|---|---|---|---|---|
| Operating income | -$672,162 | -$18,911 | -$1.2M | -$757,935 |
| Net income | -$672,162 | -$18,911 | -$1.0M | $3.7M |
| Diluted EPS | — | $0.01 | -$0.11 | $0.40 |
| Operating cash flow | -$72,250 | -$209 | -$1.0M | -$316,132 |
| Total assets | $1.7M | $6,252 | $203,079 | $4.2M |
| Total liabilities | $169,490 | $29,322 | $589,413 | $3.7M |
| Stockholders' equity | $1.5M | -$29,322 | -$20,000 | $456,450 |
| Cash and investments | $81,179 | $823 | $176,424 | $569,378 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 30, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 9, 2026 | Oct 8, 2026 |
| 8-K |
Current report
Auditor change
|
Oct 7, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 23, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Sep 17, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Aug 12, 2026 | Aug 11, 2026 |
All 416 CTT Pharmaceutical Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.